What’s the newest analysis saying about fibromyalgia and hashish?

Article content continued

This chronic condition can lead to insomnia or sleep disorders, fatigue and lethargy, and even emotional or psychological distress. In addition to these problems, the most common symptoms of fibromyalgia include headaches and migraines, depression and anxiety, memory and concentration problems, and general body stiffness. In addition, fibromyalgia often leads to damage to a person’s quality of life and general well-being.

Cannabis can provide a light at the end of the tunnel for fibromyalgia sufferers, especially in terms of its analgesic properties.

Medicines and over-the-counter pain relievers (OTC) are usually used to treat fibromyalgia. However, new medical evidence shows that cannabinoids like CBD and THC are being considered more often now.

The evolving relationship between fibromyalgia and cannabis

Cannabinoids can act as analgesics, as shown by recent research that supports cannabinoids as pain relievers for fibromyalgia.

For example, a randomized controlled trial was conducted for 2020 to understand how THC-rich whole cannabis vegetable oil can help fibromyalgia patients manage their symptoms and improve their quality of life. It was concluded that phytocannabinoids could serve as an affordable yet well-tolerated therapy for alleviating fibromyalgia symptoms and improving quality of life.

The researchers also suggested that cannabinoid therapy method could become a herbal / holistic medicine choice to treat fibromyalgia as part of the Brazilian public health system.

The importance of the endocannabinoid system

Regardless of the latest evidence, more studies are needed to better understand phytocannabinoids and fibromyalgia. Additional studies on the body’s deregulations and deficiencies in the endocannabinoid system (ECS) and the endocannabinoid system are also warranted.

Researchers from the 2020 Controlled Study said of the ECS and conditions such as fibromyalgia, “Some studies suggest that pathological conditions in pain modulation such as fibromyalgia, migraines, and irritable bowel syndrome may be at least partially related, among other things, to the deregulation of the endocannabinoid system. “

Comments are closed.